Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/3/2025

A1C Screening Guidelines for Adolescents and Adults

Age-Based Screening Recommendations

  • The American Diabetes Association recommends that screening for type 2 diabetes should begin at age 45 years in adults without any risk factors 1, 2
  • For adults aged 40-70 years with BMI ≥25 kg/m², A1C testing is recommended 2

Risk-Based Screening in Adolescents

  • Risk-based screening should be considered after the onset of puberty or ≥10 years of age (whichever occurs earlier) only in youth with overweight (BMI ≥85th percentile) or obesity (BMI ≥95th percentile) AND one or more additional risk factors for diabetes 3, 4, 5
  • The American Diabetes Association identifies additional risk factors that would warrant screening, including having a first-degree relative with diabetes 1
  • High-risk race/ethnicity (African American, Latino, Native American, Asian American, Pacific Islander) is also a risk factor that would warrant screening 1
  • Maternal history of gestational diabetes is a risk factor that would warrant screening 4
  • Signs of insulin resistance (such as high blood pressure, high cholesterol, or polycystic ovary syndrome) are risk factors that would warrant screening 1
  • Physical inactivity is a risk factor that would warrant screening 1

Key Clinical Considerations

  • If initial screening is normal, repeat testing should occur at minimum 2-3 year intervals, not annually 4, 5
  • The U.S. diabetes guidelines suggest that the dramatic increase in type 2 diabetes prevalence in youth primarily affects those with obesity and other risk factors, not healthy-weight adolescents without risk factors 4, 5
  • The American Diabetes Association recommends against universal screening of all adolescents, as this leads to unnecessary testing and potential false positives 2
  • A1C may underestimate blood sugar levels in certain populations and has limited validation data in pediatric populations, though it remains the recommended screening test when indicated 6, 7